Business Wire
BusinessEli Lilly to buy Merida Biosciences for $2.88 billion, setting off investor focus on the deal’s strategic fitThe Apex TimesBusinessApple says it has evidence a former employee destroyed material after learning of an investigationThe Apex TimesBusinessTelecom comparison turns on profitability pace versus leverage: AT&T’s margin jump, Verizon’s debt loadThe Apex TimesBusinessAnthropic agrees to a $35 billion cloud computing deal tied to Nvidia-backed Lambda, report saysThe Apex TimesBusinessAMD has tended to fall in September, but market history is only part of the storyThe Apex TimesBusinessDuolingo shares jump after results point to steady user momentum, according to Yahoo FinanceThe Apex TimesBusinessNetflix confirms production of Korean series “Materesa (WT),” led by “Queen of Tears” director and writers behind “The East Palace”The Apex TimesBusinessFTC and 22 States Sue Amazon, Alleging It Secretly Marked Up Ads Shown to Marketplace SellersThe Apex TimesBusinessDeere shares gained as market focused on a jump in profitsThe Apex TimesBusinessBaird lifts Deere to Outperform, citing potential agricultural recovery and raises target to $800The Apex TimesBusinessVenezuela’s energy reopening talks could create upside for Chevron and GE Vernova, but agreements still face major hurdlesThe Apex TimesBusinessTrump Says ExxonMobil Is Preparing to Re-enter Venezuela as Investment Outlook ShiftsThe Apex TimesBusinessEli Lilly to buy Merida Biosciences for $2.88 billion, setting off investor focus on the deal’s strategic fitThe Apex TimesBusinessApple says it has evidence a former employee destroyed material after learning of an investigationThe Apex TimesBusinessTelecom comparison turns on profitability pace versus leverage: AT&T’s margin jump, Verizon’s debt loadThe Apex TimesBusinessAnthropic agrees to a $35 billion cloud computing deal tied to Nvidia-backed Lambda, report saysThe Apex TimesBusinessAMD has tended to fall in September, but market history is only part of the storyThe Apex TimesBusinessDuolingo shares jump after results point to steady user momentum, according to Yahoo FinanceThe Apex TimesBusinessNetflix confirms production of Korean series “Materesa (WT),” led by “Queen of Tears” director and writers behind “The East Palace”The Apex TimesBusinessFTC and 22 States Sue Amazon, Alleging It Secretly Marked Up Ads Shown to Marketplace SellersThe Apex TimesBusinessDeere shares gained as market focused on a jump in profitsThe Apex TimesBusinessBaird lifts Deere to Outperform, citing potential agricultural recovery and raises target to $800The Apex TimesBusinessVenezuela’s energy reopening talks could create upside for Chevron and GE Vernova, but agreements still face major hurdlesThe Apex TimesBusinessTrump Says ExxonMobil Is Preparing to Re-enter Venezuela as Investment Outlook ShiftsThe Apex TimesBusinessEli Lilly to buy Merida Biosciences for $2.88 billion, setting off investor focus on the deal’s strategic fitThe Apex TimesBusinessApple says it has evidence a former employee destroyed material after learning of an investigationThe Apex TimesBusinessTelecom comparison turns on profitability pace versus leverage: AT&T’s margin jump, Verizon’s debt loadThe Apex TimesBusinessAnthropic agrees to a $35 billion cloud computing deal tied to Nvidia-backed Lambda, report saysThe Apex TimesBusinessAMD has tended to fall in September, but market history is only part of the storyThe Apex TimesBusinessDuolingo shares jump after results point to steady user momentum, according to Yahoo FinanceThe Apex TimesBusinessNetflix confirms production of Korean series “Materesa (WT),” led by “Queen of Tears” director and writers behind “The East Palace”The Apex TimesBusinessFTC and 22 States Sue Amazon, Alleging It Secretly Marked Up Ads Shown to Marketplace SellersThe Apex TimesBusinessDeere shares gained as market focused on a jump in profitsThe Apex TimesBusinessBaird lifts Deere to Outperform, citing potential agricultural recovery and raises target to $800The Apex TimesBusinessVenezuela’s energy reopening talks could create upside for Chevron and GE Vernova, but agreements still face major hurdlesThe Apex TimesBusinessTrump Says ExxonMobil Is Preparing to Re-enter Venezuela as Investment Outlook ShiftsThe Apex TimesBusinessEli Lilly to buy Merida Biosciences for $2.88 billion, setting off investor focus on the deal’s strategic fitThe Apex TimesBusinessApple says it has evidence a former employee destroyed material after learning of an investigationThe Apex TimesBusinessTelecom comparison turns on profitability pace versus leverage: AT&T’s margin jump, Verizon’s debt loadThe Apex TimesBusinessAnthropic agrees to a $35 billion cloud computing deal tied to Nvidia-backed Lambda, report saysThe Apex TimesBusinessAMD has tended to fall in September, but market history is only part of the storyThe Apex TimesBusinessDuolingo shares jump after results point to steady user momentum, according to Yahoo FinanceThe Apex TimesBusinessNetflix confirms production of Korean series “Materesa (WT),” led by “Queen of Tears” director and writers behind “The East Palace”The Apex TimesBusinessFTC and 22 States Sue Amazon, Alleging It Secretly Marked Up Ads Shown to Marketplace SellersThe Apex TimesBusinessDeere shares gained as market focused on a jump in profitsThe Apex TimesBusinessBaird lifts Deere to Outperform, citing potential agricultural recovery and raises target to $800The Apex TimesBusinessVenezuela’s energy reopening talks could create upside for Chevron and GE Vernova, but agreements still face major hurdlesThe Apex TimesBusinessTrump Says ExxonMobil Is Preparing to Re-enter Venezuela as Investment Outlook ShiftsThe Apex Times
Back to front
Moderna schedules live webcast and conference call for second-quarter 2026 results on Friday, July 31
The Apex Times

THE APEX TIMES

Business/The Apex Times/Jul 13, 3:35 PM EDT

Moderna schedules live webcast and conference call for second-quarter 2026 results on Friday, July 31

The Cambridge, Massachusetts biotech said it will report second-quarter 2026 financial results with a live call and webcast set for 8:00 a.m. ET.

Moderna said it will release its second-quarter 2026 financial results on Friday, July 31, 2026, and will host a live conference call and webcast the same morning.

The company, based in Cambridge, Massachusetts, scheduled the event for 8:00 a.m. ET. Investors and other participants will be able to follow the discussion via webcast, alongside the live conference call format described in the announcement.

The disclosure comes as Moderna continues operating in a competitive vaccine and therapeutics landscape, where the timing and content of quarterly updates often shape expectations for pipeline progress and financial performance.

While Moderna did not provide additional quarter-specific figures in the announcement, such calls typically serve as the venue for management to discuss reported results and key developments during the quarter, including progress on its product portfolio and operating priorities.

For shareholders, the date is also a practical marker for when the company’s latest revenue and expense picture will be made public, along with any guidance or qualitative commentary management chooses to include.

Beyond the scheduled call, details about what will be covered in the webcast, whether the company will open the floor to live questions, and any supporting materials typically associated with quarterly reporting were not included in the brief notice.

In recent years, Moderna has relied on quarterly earnings communications to pair financial disclosures with updates on clinical and regulatory milestones. How much incremental information management plans to emphasize for the July 31 call will likely become clearer as the company releases its earnings materials ahead of the event.

Investors will want to review the company’s earnings release itself, which should include the full set of financial statements, management’s discussion, and any forward-looking statements. The announcement announcing the call did not include those specifics, so the underlying performance details are not yet available from the notice alone.

Why It Matters

  • The July 31 earnings event is the next scheduled opportunity for Moderna to update markets on its quarterly financial performance and operating progress.
  • An early-morning call and webcast typically functions as the main platform for management’s interpretation of results, which can influence near-term sentiment.
  • For investors tracking Moderna’s program and commercial trajectory, the content of management commentary may affect expectations ahead of subsequent clinical and regulatory developments.
  • Because the notice does not include numbers, the full earnings release will be necessary to assess performance and any changes in outlook.

Sources

Key Facts

  • Moderna said it will report second-quarter 2026 financial results on Friday, July 31, 2026.
  • The company scheduled a live conference call and webcast for 8:00 a.m. ET on July 31, 2026.
  • The announcement was issued from Cambridge, Massachusetts.
  • The company’s communication describes the event but does not include second-quarter 2026 financial figures in the notice.

Healthcare Related

Moderna schedules live webcast and conference call for second-quarter 2026 results on Friday, July 31 | The Apex Times